These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3042432)

  • 41. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
    Ahrén B; Holst JJ; Mårtensson H; Balkan B
    Eur J Pharmacol; 2000 Sep; 404(1-2):239-45. PubMed ID: 10980284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central administration of alloxan impairs glucose tolerance in rats.
    Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P
    J Neural Transm (Vienna); 2005 Oct; 112(10):1391-5. PubMed ID: 16184320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.
    Feigh M; Hjuler ST; Andreassen KV; Gydesen S; Ottosen I; Henriksen JE; Beck-Nielsen H; Christiansen C; Karsdal MA; Henriksen K
    Eur J Pharmacol; 2014 Aug; 737():91-6. PubMed ID: 24858364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
    Hamada Y; Ikegami H; Ueda H; Kawaguchi Y; Yamato E; Nojima K; Yamada K; Babaya N; Shibata M; Ogihara T
    Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats.
    Park S; Kang S; Lee HW; Ko BS
    Neuroendocrinology; 2012; 95(4):332-43. PubMed ID: 22441304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats.
    Kim DS; Kang S; Moon NR; Park S
    Cytokine; 2014 Feb; 65(2):159-66. PubMed ID: 24332931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STAT5 activity in pancreatic beta-cells influences the severity of diabetes in animal models of type 1 and 2 diabetes.
    Jackerott M; Møldrup A; Thams P; Galsgaard ED; Knudsen J; Lee YC; Nielsen JH
    Diabetes; 2006 Oct; 55(10):2705-12. PubMed ID: 17003334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement of Glucose Metabolism Following Long-Term Taurocholic Acid Gavage in a Diabetic Rat Model.
    Cheng Z; Liu G; Zhang X; Bi D; Hu S
    Med Sci Monit; 2018 Oct; 24():7206-7212. PubMed ID: 30298865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Current views on the mode of action of hypoglycemic sulfonamides].
    Creutzfeldt W
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():201-15. PubMed ID: 4906019
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term effects of alloxan in mice.
    Ahrén B; Sundkvist G
    Int J Pancreatol; 1995 Apr; 17(2):197-201. PubMed ID: 7622942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells develop diabetes.
    Davani B; Portwood N; Bryzgalova G; Reimer MK; Heiden T; Ostenson CG; Okret S; Ahren B; Efendic S; Khan A
    Diabetes; 2004 Feb; 53 Suppl 1():S51-9. PubMed ID: 14749266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA; Carroll MJ; Levy AL; Lister CA; Sennitt MV; Smith SA; Young P
    Int J Obes; 1984; 8 Suppl 1():93-102. PubMed ID: 6152558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of frusemide, piretanide and bumetanide on cochlear succinic dehydrogenase.
    Comis SD; Pratt SR; Hayward TL
    Neuropharmacology; 1981 Apr; 20(4):405-7. PubMed ID: 7290353
    [No Abstract]   [Full Text] [Related]  

  • 54. Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonist.
    Tanaka H; Shimaya A; Kiso T; Kuramochi T; Shimokawa T; Shibasaki M
    Life Sci; 2011 Mar; 88(11-12):559-63. PubMed ID: 21277869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.
    Leng SH; Lu FE; Xu LJ
    Acta Pharmacol Sin; 2004 Apr; 25(4):496-502. PubMed ID: 15066220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats.
    Stephen Irudayaraj S; Christudas S; Antony S; Duraipandiyan V; Naif Abdullah AD; Ignacimuthu S
    Pharm Biol; 2017 Dec; 55(1):1074-1081. PubMed ID: 28193094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
    O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
    Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dietary treatment ameliorates overt diabetes and decreased insulin secretion to glucose, induced by overeating in impaired glucose tolerant mice.
    Hasegawa G; Mori H; Sawada M; Takagi S; Shigeta H; Kitagawa Y; Nakano K; Kanatsuna T; Kondo M
    Horm Metab Res; 1990 Aug; 22(8):408-12. PubMed ID: 2172133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.